OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 01, 2023
As the development of increasingly complex biologics grows, more robust bioassays are required to accurately characterize these molecules.
Analytical techniques for validating cleaning methods must evolve to match the pace of an increasingly complex manufacturing landscape for new therapeutics.
December 19, 2022
The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.
December 07, 2022
One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.
Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.
December 03, 2022
Although well known in R&D, PK/PD studies are an equally powerful tool for promoting successful biologic drug development.
December 02, 2022
Dissolution testing is experiencing a refresh thanks to a variety of market drivers.
November 21, 2022
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
November 02, 2022
Replacing a step in sample preparation with an automated approach improves both method precision and productivity.
Experts discuss factors that can affect the outcome of an ADME study, signs that a drug compound shows promise, red flags, and key parameters to determine safety and efficacy.